Grupo para la caracterización molecular de las neoplasias hematológicas

Foto de Grupo para la caracterización molecular de las neoplasias hematológicas

Foto de Sahlgrenska University Hospital

Sahlgrenska University Hospital

Gotemburgo, Suecia

Publikationen in Zusammenarbeit mit Forschern von Sahlgrenska University Hospital (6)

2023

Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study
HemaSphere, Vol. 7, Núm. 9, pp. E942

2017

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448

2016

International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2014

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis
Haematologica
New drugs and novel mechanisms of action in multiple myeloma in 2013: A report from the International Myeloma Working Group (IMWG)
Leukemia, Vol. 28, Núm. 3, pp. 525-542

2013

Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Leukemia, Vol. 27, Núm. 4, pp. 780-791